SAHPRA Offices will be unavailable on 29 November 2024
Please note that SAHPRA Head Office, including Cape Town and Durban Regional Offices will be unavila...
29 November, 24Please note that SAHPRA Head Office, including Cape Town and Durban Regional Offices will be unavila...
29 November, 24SAHPRA offices will be closed for the festive season from 12:00 on Tuesday, 24 December 2024 and wil...
22 November, 24Pretoria, 21 November 2024 – The South African Health Products Regulatory Authority (SAHPRA) is awar...
21 November, 24Pretoria, 08 November 2024 –The South African Health Products Regulatory Authority (SAHPRA) is conce...
08 November, 24There have been several cases around the world in which Tranexamic acid has been administered intrat...
21 December, 23The South African Health Products Regulatory Authority (SAHPRA) would like to inform you of a signal...
19 October, 21In collaboration with the South African Health Products Regulatory Authority (SAHPRA), Roche Product...
10 November, 20SAHPRA alerts all healthcare professionals about the risk of serious heart problems, seizures, coma ...
01 November, 20The recall is initiated because some units of the batch presented with low fill volumes, and therefore does not meet the final product specifications with respect to the volume.
The recall is initiated because instances of precipitation of the active ingredient paracetamol have been detected and therefore the product does not meet the final product specifications with respect to visual description.
This recall is initiated due to a limited number of packs found in retail Pharmacy, with mix-up of the sequence of hormone-containing and hormone-free tablets, wherein some packs had • 24 light orange hormone-free, and • 4 pink film-coated hormone tablets Instead of • 24 pink film-coated hormone tablets and • 4 light orange hormone-free tablets.